PMS Study of MicardisPlus Tablet.

Trial Profile

PMS Study of MicardisPlus Tablet.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Jul 2014

At a glance

  • Drugs Telmisartan/hydrochlorothiazide (Primary)
  • Indications Essential hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms PMS
  • Sponsors Boehringer Ingelheim
  • Most Recent Events

    • 23 Oct 2009 Planned number of patients changed from 6764 to 6901 as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Actual initiation date (Sep 2003) added as reported by ClinicalTrials.gov.
    • 28 Jan 2009 Planned number of patients changed from 7000 to 6764 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top